Skip to content

CLYMCLIMB BIO INC

CUSIP 28658R106 · common stock

3 tracked investors held CLIMB BIO INC (CLYM) at the end of Q3 2026, worth $125.8M in total. The largest holder was RA Capital Management, with 1.2% of its portfolio. Ken Fisher opened a new position this quarter.

Holders · Q3 2026
3
New holders
1
Value held
$125.8M
Quarter-end price (est.)
$11.47

Investors holding CLYM · Q3 2026

InvestorWeightSharesValueChange
RA Capital Management
RA Capital Management, L.P.
1.17%10,130,130$116.2MREDUCE-10.4%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.39%792,936$9.1MREDUCE-3.6%
Ken Fisher
Fisher Asset Management, LLC
0.00%43,996$504.6KNEW

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026310$125.8M$11.47
Q2 2026200$158.1M$13.04
Q1 2026200$81.5M$6.85
Q4 2025200$83.4M$6.56